Xarelto Litigation Progresses Amid Growing Sales

Posted on August 8, 2016

As sales of Johnson & Johnson and Bayer’s blood thinning medication Xarelto (Rivaroxaban) continue to grow, so does the list of plaintiffs suing the pharmaceutical giants for the drug’s potentially fatal side effects. Xarelto was approved by the U.S. Food and Drug Administration (FDA) in 2011 for treatment of patients suffering from blood clots and to lower the risk of stroke, deep vein thrombosis, and pulmonary embolism.

The anticoagulant quickly became the most prescribed medication of its type, making billions for its makers. But Xarelto’s blood thinning capabilities have led to serious injuries in patients, including excessive bleeding and bruising, internal bleeding, and heavy menstrual bleeding.  So far there have been well over 5,200 lawsuits against Xarelto’s manufacturers, and the number continues to grow. Adding fuel to the claims against the medication are allegations that Johnson & Johnson and Bayer withheld key information about the drug, and the fact that initial testing was done with a blood monitoring device that has since been recalled.

If you were prescribed Xarelto and suffered side effects, or, if you’ve lost a loved one due to complications involving Xarelto use, you may have grounds for legal action. In a lawsuit against Xarelto’s manufacturer, you may be able to recover lost wages from missed work, medical bills you’ve accumulated, and damages for pain and suffering, permanent injury, wrongful death, and more. But to take on a powerful entity like a pharmaceutical corporation, it is vital that you seek the representation of a skilled personal injury attorney.

The legal team at the law offices of Farah & Farah has been successfully represent injury victims and their families for over 35 years. We are currently investigating Xarelto related injuries nationwide. Call Farah & Farah today for a free consultation by dialing (800) 533-3555.


  • This field is for validation purposes and should be left unchanged.